Florian J. Fintelmann
@F_Fintelmann_MD
Followers
703
Following
152
Media
22
Statuses
204
Thoracic Interventional Oncologist | Head, Thoracic Imaging Percutaneous Ablation @MGHimaging | Associate Professor @HarvardMed #lungcancer #BodyComp Tweets=own
Boston, MA
Joined May 2013
RT @MassGenBrigham: At Mass General Brigham, #WeAreOneAgainstCancer. With the most cancer specialists in New England, our dedicated team wo….
0
4
0
RT @VTaqMD: Scientists uncover new heart risk hiding between your muscle fibers @escardio @anachsouza.@michael_t_l….
studyfinds.org
Learn about the connection between hidden heart fat and inflammation and blood vessel problems. Find out why this fat can damage your heart.
0
2
0
0
1
0
RT @SIO_Central: We’re thrilled to share that Florian Fintelmann, MD — a recipient of the SIO BTG grant — has led a pivotal pilot study ex….
0
1
0
RT @HenningWillers: Big shoutout 🔊 to multidisciplinary care + collaboration in the management of lung cancer & mets 👍🙏.#lcsm #radiology #….
link.springer.com
Annals of Surgical Oncology - This study aimed to describe lesion-specific management of thoracic tumors referred for consideration of image-guided thermal ablation (IGTA) at a newly established...
0
3
0
Congratulations 🍾 to my 🎓student Alexander Graur on his 📰 detailing our weekly multidisciplinary Thoracic Ablation Conference which provides lesion-specific management recommendations for #lungcancer and pulmonary metastases (#surgery SBRT ablation) 👉
1
1
9
🚀 your body composition research with age- and sex-adjusted reference values for skeletal muscle cross-sectional area, density, gauge, SMI on Chest and Abdomen CT of the Framingham Heart Study 🫀Free online Z-score calculator, including batch processing!!
0
2
14
Our lab website was just redone - let’s see if the Twitter fees will require tweaking? Excited to update the team roster and add an updated group picture!!.
1
0
8
👍 🩻 radiology-☢️radiation oncology @ASarafMD2 collaboration leveraging radiation planning CT for muscle analysis in women with early-stage breast cancer to understand the link with toxicity-related discontinuation of adjuvant endocrine therapy 👉 @IJROBP
0
3
13
Patients with Li-Fraumeni Syndrome #LFS have limited options for managing lung 🫁 metastases. Multimodality management with ablation and surgery can help as illustrated in this case report >>>@LivingLFS @LFSAssociation.
1
0
5
No doubt: Lung 🫁 needle biopsy is safe and effective for diagnosing lung cancer and metastases to the lung, infection, getting tissue for molecular testing to inform targeted therapy and more. A time-proven and cost-effective tool.👌👉
0
0
7
RT @SIO_Central: Dr. Sun Ahn, an expert in the field, will provide invaluable insights into IR/DR residency applications. Learn effective s….
0
2
0
Huge congratulations 🥂to my mentee and doctoral student Georg Fuchs who passed his oral M.D. Ph.D. defense @ChariteBerlin today with the outstanding grade "summa cum laude" 🎓🍾 It's been the most rewarding journey @AsbachP @RyanNipp.
0
1
16
RT @MGHCancerCenter: Don't miss ⬇️. ✳️ #8 "Defining a New Era of Precision Oncology" (@davetingmgh, MD).✳️ #9 "AI Tool Predicts Lung Cancer….
worldmedicalinnovation.org
0
1
0
RT @MassGeneralNews: Mass General researchers summarized findings on #lungcancer in patients w/ interstitial lung disease (ILD), including….
0
4
0
Dr Erica Warner, ScD, MPH @ewarner_12 presenting on the Fire Health Study at the 🫁 SPORE workshop- this ongoing study was designed to improve early cancer detection in fire fighters. If you know a fire fighter they may want to participate! 🚒👩🚒
0
1
9
Patients with #interstitialLungDisease have severely limited options for treating #lungcancer. 🙌 to my PostDoc for showing that ❄️cryoablation of stage IA NSCLC is well tolerated in #interstitialLungDisease. No ILD exacerbations within 90d + PFS 97% at 1year @OncoAlert
0
5
30
Artificial intelligence keeps evolving quickly. In this article, we summarized how it may soon affect lung cancer screening #lungcancer
0
0
13
Important work for patients with interstitial lung disease/lung fibrosis.
Report on cryoablation for stage IA NSCLC in pts with and without ILD @LungCaJournal by @F_Fintelmann_MD and team. ILD did not impact safety or efficacy. No ILD exacerbations within 90d. Recurrence free survival 97% at 1y.
0
0
4